Table 2.
Comparison of the characteristics of survivors and nonsurvivors
| Survivors (N = 26) | Nonsurvivors (N = 34) | P value | |
|---|---|---|---|
| Age, years | 48.2 ± 13.0 | 53.9 ± 12.1 | 0.085 |
| Men, n (%) | 20 (77) | 25 (74) | 0.764 |
| Body mass index, kg/m2 | 22.5 ± 3.2 | 24.1 ± 4.5 | 0.109 |
| Concomitant disease, n (%) | |||
| Atrail fibrillation | 6 (23) | 5 (15) | 0.406 |
| Pulmonary arterial hypertension | 8 (31) | 4 (12) | 0.068 |
| Renal failure | 0 (0) | 2 (6) | 0.501 |
| History of cardiac surgery, n (%) | 4 (15) | 4 (12) | 0.717 |
| Surgery procedure, n (%) | |||
| Emergency surgery | 7 (27) | 12 (35) | 0.490 |
| Off‐pump surgery | 2 (8) | 5 (15) | 0.402 |
| Secondary exploratory thoracotomy | 6 (23) | 9 (26) | 0.764 |
| Heart transplantation | 14 (54) | 9 (26) | 0.037 |
| CABG | 9 (35) | 17 (50) | 0.233 |
| Preoperative test | |||
| Albumin, g/L | 40.9 ± 4.3 | 42.3 ± 4.9 | 0.246 |
| Total bilirubin, μmol/L | 27.2 ± 11.9 | 29.9 ± 28.9 | 0.669 |
| BUN, mmol/L | 9.4 ± 6.2 | 14.5 ± 33.2 | 0.443 |
| Creatinine, μmol/L | 87.1 ± 23.8 | 88.9 ± 22.5 | 0.759 |
| PTT, s | 13.9 ± 1.6 | 13.8 ± 1.1 | 0.677 |
| LDH, IU/L | 205.4 ± 106.1 | 193.1 ± 48.5 | 0.586 |
| HSCRP, mg/L | 2.8 ± 3.0 | 2.7 ± 2.6 | 0.934 |
| ECMO implantation | |||
| Bedside implantation, n (%) | 3 (12) | 14 (41) | 0.012 |
| Concurrently with IABP, n (%) | 21 (81) | 17 (50) | 0.014 |
| ECMO supporting time, days | 5.6 ± 2.0 | 5.0 ± 3.2 | 0.373 |
| IABP supporting time, days | 7.8 ± 2.8 | 6.3 ± 5.1 | 0.140 |
BUN, blood urea nitrogen; CABG, coronary artery bypass grafting; ECMO, extracorporeal membrane oxygenation; HSCRP, high sensitivity C‐reactive protein; IABP, intra‐aortic balloon pump; LDH, lactic dehydrogenase; PTT, prothrombin time.